View the BOLT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bolt Biotherapeutics. Completed upsized Initial Public Offering in February – In February , Bolt completed its Initial Public Offering (IPO) of 13,, shares of common. The Investor Relations website contains information about Bolt Biotherapeutics's business for stockholders, potential investors, and financial analysts. If the lower trend floor at $ is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -. Research Bolt Biotherapeutics' (Nasdaq:BOLT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance.
Bolt Biotherapeutics Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. BOLT - Bolt Biotherapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). Bolt Biotherapeutics Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · BOLT Overview · Key Data · Performance · Analyst Ratings. Sell. The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $ last updated September 3, at PM EDT. Q. Does Bolt Biotherapeutics (BOLT). Track Bolt Biotherapeutics Inc (BOLT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Currently, Wall Street analysts rate BOLT as Neutral on average. Additionally, the current consensus price target from analysts is $ To see all of BOLT's. In the current month, BOLT has received 3 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. BOLT average Analyst price target in the past 3 months is $ What is Bolt Biotherapeutics stock price doing today? As of August 2, , BOLT stock price was flat at $ with , million shares trading. Bolt Biotherapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 04, (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment. Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer.
Bolt Biotherapeutics (Nasdaq: BOLT) reports positive progress in Phase 2 studies for BDC and successful safety assessments for BDC The company's cash. Find the latest Bolt Biotherapeutics, Inc. (BOLT) stock quote, history, news and other vital information to help you with your stock trading and investing. Bolt Biotherapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Bolt Biotherapeutics Inc Ordinary Shares BOLT ; Valuation · Price/Earnings (Normalized). — ; Financial Strength · Quick Ratio. ; Profitability · Return on Assets. Discover real-time Bolt Biotherapeutics, Inc. Common Stock (BOLT) stock prices, quotes, historical data, news, and Insights for informed trading and. Over the last year, Bolt Biotherapeutics shares have traded in a share price range of $ to $ Bolt Biotherapeutics currently has 38,, shares. Stock analysis for Bolt Biotherapeutics Inc (BOLT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. View Bolt Biotherapeutics, Inc. BOLT stock quote prices, financial information, real-time forecasts, and company news from CNN. Adagene Inc. $ ADAG % ; Spruce Biosciences Inc. $ SPRB % ; In the news. Stock Titan. 1 day ago. Bolt Biotherapeutics Announces Changes to its.
Bolt Biotherapeutics (BOLT) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Bolt Biotherapeutics Inc BOLT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date04/01/24 · 52 Week Low. Bolt Biotherapeutics, Inc. (formula-line.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Bolt Biotherapeutics. Bolt Biotherapeutics Inc ; Previous Close: ; Open: ; Volume: 30, ; 3 Month Average Trading Volume: ; Shares Out (Mil): As of Jul the stock price of Bolt Biotherapeutics is $ What is the current market cap of Bolt Biotherapeutics? The current market capitalization of.
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and. Trade Bolt Biotherapeutics, Inc. - BOLT CFD ; Prev. Close, ; Open, ; 1-Year Change, % ; Day's Range, - Bolt Biotherapeutics Market Cap. Bolt Biotherapeutics has a market cap or net worth of $ million as of August 30, Its market cap has decreased by -. Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer.
Trade Futures For Less | How Does Mega Backdoor Roth Work